Menu
Live News EQUITY M impact

NVCT Licenses Compounds

Nuvectis Pharma strikes license agreement with Haisco Pharmaceutical Group for exclusive ex-China rights to two compounds

NVCT

Nuvectis Pharma Strikes License Agreement With Haisco Pharmaceutical Group For Exclusive Ex-China Rights To Two Compounds